Skip to main content

Advertisement

SpringerLink
Log in

In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

We report a case of neonatal transient renal failure after maternal ingestion of diclofenac, paracetamol, and nimesulide during pregnancy. The baby girl was delivered at the 33 weeks gestation for complete absence of amniotic fluid. Acute renal failure was present. Urine output started 12 h after birth, increasing to polyuria on day 6, and then decreasing gradually to normal values. Serum creatinine normalized on day 6. Several cases of severe and sometimes irreversible renal problems have been described in neonates exposed to indomethacin, a non-selective cyclooxgenase (COX) inhibitor, during their fetal life. More recently, the use of nimesulide, a selective COX-2 inhibitor, as a tocolytic agent has been advocated. Although it is difficult to ascribe the observed side effects to one specific drug in our patient, using the Naranjo ADR probability scale, renal failure was probably related to nimesulide exposure. Paracetamol is considered safe at therapeutic doses, and there are no reports of prenatal diclofenac toxicity. However, recently there have been some reports of neonatal renal failure associated with maternal nimesulide consumption and probably modulated by genetic factors. Hence, cautious use of nimesulide during pregnancy must be advocated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Moise KJ Jr, Huhta JC, Sharif DS, Ou CN, Kirshon B, Wasserstrum N, Cano L (1988) Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 319:327–331

    PubMed  Google Scholar 

  2. Mamopoulos M, Assimakopoulos E, Reece EA, Andreou A, Zheng XZ, Mantalenakis S (1990) Maternal indomethacin therapy in the treatment of polyhydramnios. Am J Obstet Gynecol 162:1225–1229

    CAS  PubMed  Google Scholar 

  3. Vermillion ST, Scardo JA, Lashus AG, Wiles HB (1997) The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 177:256–271

    CAS  PubMed  Google Scholar 

  4. Cuzzolin L, Dal Cerè M, Fanos V (2001) NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 24:9-18

    CAS  PubMed  Google Scholar 

  5. Dubose TD (1994) Grand round: nephrotoxicity of non-steroidal antiinflammatory drugs. Lancet 344:515–518

    Article  PubMed  Google Scholar 

  6. Bennett W, Henrich W, Stoff JS (1996) The renal effects of non-steroidal antiinflammatory drugs. Summary and recommendations. Am J Kidney Dis 26:S56–S62

    Google Scholar 

  7. Slater D, Berger L, Moore GE, Bennett P (1995) Changes in the expression of types 1 and 2 cyclo-oxygenase in human fetal membranes at term. Am J Obstet Gynecol 172:77–82

    CAS  PubMed  Google Scholar 

  8. Sawdy R, Slater D, Fisk N, Edmonds DK, Bennett P (1997) Use of a cyclo-oxygenase type 2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 350:265–266

    CAS  PubMed  Google Scholar 

  9. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM (1997) Localization of cyclooxygenase-1 and −2 in adult and fetal human kidney: implication for renal function. Am J Physiol 272:460–468

    Google Scholar 

  10. Zhang M, Wang J, Cheng HF, Harris RC, McKanna JA (1997) Cyclooxygenase-2 in rat nephron development. Am J Physiol 273:F994–F1002

    CAS  PubMed  Google Scholar 

  11. Komhoff M, Wang J, Cheng H, Langenbach R, McKanna JA, Harris RC, Breyer MD (2000) Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57:414–422

    CAS  PubMed  Google Scholar 

  12. Cuzzolin L, Mangiarotti P, Fanos V (2001) Urinary PGE2 concentrations measured by a new EIA method in infants with urinary tract infections or renal malformations. Prostaglandins Leukot Essent Fatty Acids 64:317–322

    Article  CAS  PubMed  Google Scholar 

  13. Agostiniani R, Mariotti P, Cataldi L, Fanos V, Sani S, Zaccaron A, Cuzzolin L (2002) Role of renal PGE2 in the adaptation from foetal to extrauterine life in term and preterm infants. Prostaglandins Leukot Essent Fatty Acids 67:373–377

    Article  CAS  PubMed  Google Scholar 

  14. Taira T, Yoshimura A, Lizuka K, Iwasaki S, Ideura T, Koshikawa S (1993) Urinary epidermal growth factor levels in patients with acute renal failure. Am J Kidney Dis 22:656–661

    CAS  PubMed  Google Scholar 

  15. Fanos V, Cataldi L (1999) Antibacterial-induced nephrotoxicity in the newborn. Drug Saf 20:245–267

    CAS  PubMed  Google Scholar 

  16. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245

    CAS  PubMed  Google Scholar 

  17. Australian Drug Evaluation Committee (1996) Medicines in pregnancy: an Australian categorisation of risk of drug use in pregnancy. 3rd edn. ADEC, Woden

    Google Scholar 

  18. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353:307–314

    CAS  PubMed  Google Scholar 

  19. Famaaey JP (1997). In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm Res 46:437–446

    Article  PubMed  Google Scholar 

  20. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type1 selective inhibitor nimesulide as tocolytic. Lancet 354:1615

    Article  CAS  PubMed  Google Scholar 

  21. Balasubramaniam J (2000) Nimesulide and neonatal renal failure. Lancet 355:575

    CAS  Google Scholar 

  22. Landau D, Shelef I, Polacheck H, Marks K, Holcberg G (1999) Perinatal vasoconstrictive renal insufficiency associated with maternal nimesulide use. Am J Perinatol 16:441–445

    CAS  PubMed  Google Scholar 

  23. Holmes RP, Stone PR (2000) Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 96:810–811

    Article  CAS  PubMed  Google Scholar 

  24. Locatelli A, Vergani P, Bellini P, Strobelt N, Ghidini A (2001) Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin? Br J Obstet Gynaecol 108:325–326

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Division, Negrar Hospital, Verona, Italy

    Daniela Benini

  2. Section of Neonatal Intensive Care Unit, Department of Pediatrics and Clinical Medicine, University of Cagliari, Via Ospedale 119, 09124 Cagliari, Italy

    Vassilios Fanos

  3. Section of Pharmacology, Department of Medicine and Public Health, University of Verona, Verona, Italy

    Laura Cuzzolin

  4. Department of Pediatrics, University of Verona, Verona, Italy

    Luciano Tatò

Authors
  1. Daniela Benini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vassilios Fanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Cuzzolin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luciano Tatò
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vassilios Fanos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benini, D., Fanos, V., Cuzzolin, L. et al. In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 19, 232–234 (2004). https://doi.org/10.1007/s00467-003-1338-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1338-3

Keywords

Search

Navigation